{"id":"W4315929061","doi":"10.1016/j.ahj.2023.01.008","title":"Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial","year":2023,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Rivaroxaban; Aspirin; Compass; Coronary artery disease; Peripheral; Internal medicine; Cardiology; Arterial disease; Clinical trial; Vascular disease; Warfarin; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001260302,0.002013883,0.002587599,0.0003398291,0.0003387546,0.001802123,0.0008693645,0.001166972,0.003888682],"category_scores_gemma":[0.001883598,0.0005413298,0.00250685,0.0005364661,0.0009156822,0.001263134,0.0009028289,0.002625671,0.0005983097],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006206873,"about_ca_system_score_gemma":0.0008690133,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00117629,"about_ca_topic_score_gemma":0.002408843,"domain_scores_codex":[0.9994129,0.0002839152,0.00003743593,0.000119752,0.00006292358,0.0000831287],"domain_scores_gemma":[0.9989729,0.0002399118,0.0002827289,0.00009687353,0.00004968612,0.0003579431],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9438052,0.001010555,0.02718191,0.0007007178,0.009534617,0.0002183116,0.00006907271,0.001119235,0.001748898,0.0007463304,0.003498109,0.01036714],"study_design_scores_gemma":[0.7721556,0.03833158,0.1561207,0.0002277114,0.01911394,0.0005998543,0.0002534542,0.003567294,0.0008129879,0.003127712,0.005537101,0.0001519585],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9844418,0.007437053,0.0002606848,0.001429124,0.0004794115,0.0001937526,0.002107082,0.00005694496,0.003594069],"genre_scores_gemma":[0.9884478,0.002630387,0.0004269921,0.001369759,0.001464908,0.0003131422,0.002836939,0.00002066248,0.002489306],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003888682,"threshold_uncertainty_score":0.01300901,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02172399589643723,"score_gpt":0.3065573558505122,"score_spread":0.284833359954075,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}